Skip to main content
. 2014 Mar 30;39(10):2008–2017. doi: 10.1007/s11064-014-1293-3

Fig. 2.

Fig. 2

Inverse agonist activity of Pimavanserin. R-SAT™ assays were performed with 5-HT2A and 5-HT2C receptors as described [24] using the indicated concentrations of Pimavanserin. Inverse agonist activity was normalized to ritanserin (not shown)